Reflect Scientific, Inc.
RSCF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $400 | $280 | $368 | $344 |
| % Growth | 42.8% | -24% | 7.1% | – |
| Cost of Goods Sold | $171 | $100 | $226 | $286 |
| Gross Profit | $229 | $180 | $142 | $58 |
| % Margin | 57.3% | 64.4% | 38.6% | 16.9% |
| R&D Expenses | $10 | $3 | $6 | $2 |
| G&A Expenses | $189 | $192 | $0 | $0 |
| SG&A Expenses | $189 | $192 | $89 | $82 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $199 | $196 | $95 | $85 |
| Operating Income | $30 | -$16 | $48 | -$27 |
| % Margin | 7.5% | -5.6% | 12.9% | -7.7% |
| Other Income/Exp. Net | $11 | $10 | $8 | $9 |
| Pre-Tax Income | $41 | -$6 | $56 | -$18 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $41 | -$6 | $56 | -$18 |
| % Margin | 10.3% | -2.1% | 15.2% | -5.2% |
| EPS | 0.001 | -0 | 0.001 | -0 |
| % Growth | 600% | -114.3% | 450% | – |
| EPS Diluted | 0.001 | -0 | 0.001 | -0 |
| Weighted Avg Shares Out | 85,664 | 85,664 | 85,664 | 85,664 |
| Weighted Avg Shares Out Dil | 85,664 | 85,664 | 85,664 | 85,664 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $21 | $0 | $19 | $19 |
| EBITDA | $51 | -$16 | $75 | $1 |
| % Margin | 12.7% | -5.6% | 20.4% | 0.3% |